Topic: Erdheim-Chester Disease (ECD) & Histiocytosis: The Diagnosis is only the beginning – From disease biology to treatment options
12:00 PM - 1:00 PM CDT
July 16, 2026 12:00 PM CDT
Speaker: Oshrat Rokah, PhD
Molecular Research Laboratory
Assuta Medical Center
Tel-Aviv, Israel
Date: Thursday, July 16, 2026
Time: 12:00 PM CDT
Dr. Oshrat Rokah is the head of the Molecular Research Lab at Assuta Medical Center, located in Tel Aviv, Israel. She holds a PhD from the Department of Genetics in the Faculty of Medicine at Tel Aviv University. Dr. Rokah’s group were pioneers in studying microRNA expression in Erdheim-Chester Disease, contributing to a better understanding of the molecular mechanisms underlying the development of the disease and opening new avenues for therapeutic treatment. She works in close cooperation with clinical professionals, physicians, and scientists to target real clinical needs and deficiencies. As part of the dedicated clinic at Assuta Medical Center for histiocytic neoplasms, her lab is investigating the role of epigenetic mechanisms in these neoplasms. Register Here
